| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| F Seemüller, U Lewitzka, M Bauer, S Meyer, R Musil, R Schennach, M Riedel, S Doucette, H-J Mölle. The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone. Pharmacopsychiatry. vol 45. issue 7. 2013-04-26. PMID:22614116. |
the relationship of akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone. |
2013-04-26 |
2023-08-12 |
Not clear |
| Kotaro Hatta, Taro Otachi, Yasuhiko Sudo, Hironori Kuga, Hiroshi Takebayashi, Hideaki Hayashi, Ryusuke Ishii, Masataka Kasuya, Tatsuro Hayakawa, Fumiyoshi Morikawa, Kazuya Hata, Mitsuru Nakamura, Chie Usui, Hiroyuki Nakamura, Toyoaki Hirata, Yutaka Saw. A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone. Psychiatry research. vol 198. issue 2. 2013-04-23. PMID:22421064. |
a comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone. |
2013-04-23 |
2023-08-12 |
Not clear |
| Kotaro Hatta, Taro Otachi, Yasuhiko Sudo, Hironori Kuga, Hiroshi Takebayashi, Hideaki Hayashi, Ryusuke Ishii, Masataka Kasuya, Tatsuro Hayakawa, Fumiyoshi Morikawa, Kazuya Hata, Mitsuru Nakamura, Chie Usui, Hiroyuki Nakamura, Toyoaki Hirata, Yutaka Saw. A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone. Psychiatry research. vol 198. issue 2. 2013-04-23. PMID:22421064. |
we examined whether augmentation with olanzapine would be superior to increased risperidone dose among acute schizophrenia patients showing early non-response to risperidone. |
2013-04-23 |
2023-08-12 |
Not clear |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
the neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. |
2013-04-16 |
2023-08-12 |
human |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
the present study evaluates the comparative efficacy, effects on neurocognitive function, and adverse effects of aripiprazole and risperidone in the treatment of hospitalized patients with schizophrenia. |
2013-04-16 |
2023-08-12 |
human |
| Goro Sato, Shinpei Yoshimura, Hidehisa Yamashita, Yasumasa Okamoto, Shigeto Yamawak. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Hiroshima journal of medical sciences. vol 61. issue 4. 2013-04-16. PMID:23342824. |
this double-blind, cross-over study included 23 patients with schizophrenia who were randomly assigned to be treated first with either aripiprazole or risperidone. |
2013-04-16 |
2023-08-12 |
human |
| Eva Ceskova, Radovan Prikry. Importance of gender in the treatment of schizophrenia. The primary care companion for CNS disorders. vol 14. issue 6. 2013-04-16. PMID:23586000. |
to compare male and female patients participating in e-star (electronic schizophrenia treatment adherence registry), an international, prospective, observational study assessing use of risperidone long-acting injection in patients with schizophrenia or schizoaffective disorder in both the czech and slovak republics. |
2013-04-16 |
2023-08-12 |
Not clear |
| Shiou-Lan Chen, Sheng-Yu Lee, Yun-Hsuan Chang, Shih-Heng Chen, Chun-Hsieh Chu, Nian-Sheng Tzeng, I-Hui Lee, Po-See Chen, Tzung Lieh Yeh, San-Yuan Huang, Yen-Kuang Yang, Ru-Band Lu, Jau-Shyong Hon. Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 7. issue 3. 2013-04-10. PMID:22730040. |
inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan. |
2013-04-10 |
2023-08-12 |
Not clear |
| Yan Li, Huafang Li, Yan Liu, Xiaolei Yan, Ying Yue, Mincai Qia. Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study. Current medical research and opinion. vol 28. issue 10. 2013-04-03. PMID:22978771. |
comparison of quetiapine and risperidone in chinese han patients with schizophrenia: results of a single-blind, randomized study. |
2013-04-03 |
2023-08-12 |
Not clear |
| Reinhold Kilian, Tilman Steinert, Wiltrud Schepp, Prisca Weiser, Susanne Jaeger, Carmen Pfiffner, Karel Frasch, Gerhard W Eschweiler, Thomas Messer, Daniela Croissant, Thomas Becker, Gerhard Längl. Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. European archives of psychiatry and clinical neuroscience. vol 262. issue 7. 2013-03-25. PMID:22526729. |
effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. |
2013-03-25 |
2023-08-12 |
Not clear |
| Reinhold Kilian, Tilman Steinert, Wiltrud Schepp, Prisca Weiser, Susanne Jaeger, Carmen Pfiffner, Karel Frasch, Gerhard W Eschweiler, Thomas Messer, Daniela Croissant, Thomas Becker, Gerhard Längl. Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. European archives of psychiatry and clinical neuroscience. vol 262. issue 7. 2013-03-25. PMID:22526729. |
objective of this observational trial is to examine the effects of quetiapine in comparison with olanzapine and risperidone on clinical outcomes and quality of life in patients with schizophrenia and schizoaffective disorder in routine care. |
2013-03-25 |
2023-08-12 |
Not clear |
| Reinhold Kilian, Tilman Steinert, Wiltrud Schepp, Prisca Weiser, Susanne Jaeger, Carmen Pfiffner, Karel Frasch, Gerhard W Eschweiler, Thomas Messer, Daniela Croissant, Thomas Becker, Gerhard Längl. Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial. European archives of psychiatry and clinical neuroscience. vol 262. issue 7. 2013-03-25. PMID:22526729. |
374 adult persons with schizophrenia or schizoaffective disorder prescribed antipsychotic maintenance therapy with quetiapine, olanzapine, or risperidone at discharge from inpatient treatment were included. |
2013-03-25 |
2023-08-12 |
Not clear |
| Barbara Remberk, Irena Namysłowska, Filip Rybakowsk. Cognition and communication dysfunctions in early-onset schizophrenia: effect of risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 39. issue 2. 2013-03-19. PMID:22819848. |
cognition and communication dysfunctions in early-onset schizophrenia: effect of risperidone. |
2013-03-19 |
2023-08-12 |
Not clear |
| Larry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, Dong-Jing Fu, Yi-Wen Ma, Joseph Huliha. Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics. Neuropsychiatric disease and treatment. vol 9. 2013-03-18. PMID:23493643. |
paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics. |
2013-03-18 |
2023-08-12 |
human |
| Larry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, Dong-Jing Fu, Yi-Wen Ma, Joseph Huliha. Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics. Neuropsychiatric disease and treatment. vol 9. 2013-03-18. PMID:23493643. |
this post hoc subgroup analysis of a randomized, double-blind trial evaluated the response to treatment with two long-acting injectable atypical antipsychotics, ie, paliperidone palmitate and risperidone long-acting injectable (rlai), in subjects with schizophrenia experiencing clinically significant symptoms despite recent treatment with oral risperidone only or other oral antipsychotics. |
2013-03-18 |
2023-08-12 |
human |
| Arun Kandasam. Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation. The Journal of neuropsychiatry and clinical neurosciences. vol 24. issue 3. 2013-03-06. PMID:23037663. |
paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation. |
2013-03-06 |
2023-08-12 |
Not clear |
| b' Kazuhiro Tajima-Pozo, Diana Zambrano-Enriquez, Laura de Anta, Mar\\xc3\\xada Dolores Moron, Jose Luis Carrasco, Juan Jos\\xc3\\xa9 Lopez-Ibor, Marina Diaz-Mars\\xc3\\xa. Practicing exorcism in schizophrenia. BMJ case reports. vol 2011. 2013-02-19. PMID:22707465.' |
we report the case of a 28-year-old patient who had been diagnosed 5 years previously with paranoid schizophrenia (treated with clozapine, risperidone, ziprasidone and onlanzapine without a complete response) and was also receiving treatment in a first episode psychosis unit in spain. |
2013-02-19 |
2023-08-12 |
Not clear |
| Albertine A Scheltema Beduin, Marije Swets, Marise Machielsen, Nikie Korve. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. The Journal of clinical psychiatry. vol 73. issue 11. 2013-02-19. PMID:23218156. |
obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. |
2013-02-19 |
2023-08-12 |
Not clear |
| Albertine A Scheltema Beduin, Marije Swets, Marise Machielsen, Nikie Korve. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. The Journal of clinical psychiatry. vol 73. issue 11. 2013-02-19. PMID:23218156. |
to compare the prevalence of obsessive-compulsive symptoms (ocs) in a population of patients with schizophrenia taking clozapine, olanzapine, or risperidone or taking no antipsychotic medication. |
2013-02-19 |
2023-08-12 |
Not clear |
| István Gacsályi, Katalin Nagy, Katalin Pallagi, György Lévay, László G Hársing, Krisztina Móricz, Szabolcs Kertész, Péter Varga, József Haller, Gábor Gigler, Gábor Szénási, József Barkóczy, Judit Bíró, Michael Spedding, Ferenc A Anton. Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents. Neuropharmacology. vol 64. 2013-02-11. PMID:22824189. |
the introduction of atypical antipsychotics such as risperidone, olanzapine and clozapine has obviated this problem, but none of the current drugs seem to improve the cognitive deficits accompanying schizophrenia. |
2013-02-11 |
2023-08-12 |
mouse |